Sponsor:
University of Texas Southwestern Medical Center
Code:
NCT01808937
Conditions
Scleroderma, Localized
Morphea
Frontal Linear Scleroderma en Coup de Sabre
Scleroderma, Circumscribed
Scleroderma, Linear
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Accepted
Interventions
Morphea
Brief summary:
Conditions
Scleroderma, Localized
Morphea
Frontal Linear Scleroderma en Coup de Sabre
Scleroderma, Circumscribed
Scleroderma, Linear
Study ID
NCT01808937
Start date
May, 2007
Status verified date
May, 2026
Completion date
Jan, 2028
Anticipated
Primary completion date
Jan, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Accepted
Enrollment
500 participants
Anticipated
Arms
Morphea
Interventions
Morphea
Primary outcome measure
Central contacts
Locations
UT Southwestern Medical Center - Department of Dermatology
Recruiting
Dallas, Texas, United States, 75390-9069
Contacts
Principal Investigator:
Heidi Jacobe, MD, MSCS
Sponsor
University of Texas Southwestern Medical Center
Last update posted
May 12, 2026
Last verified
May, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Texas Southwestern Medical Center on 2026-05-12.